Total Payments
$3,341
2024 Payments
$957.60
Companies
24
Transactions
185
Medicare Patients
533
Medicare Billing
$59,939
Payment Breakdown by Category
Food & Beverage$3,313 (99.2%)
Education$28.33 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,313 | 182 | 99.2% |
| Education | $28.33 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $699.82 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $521.74 | 30 | $0 (2024) |
| Novo Nordisk Inc | $474.97 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $284.95 | 20 | $0 (2020) |
| Lilly USA, LLC | $180.26 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $156.06 | 9 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $118.10 | 3 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $110.14 | 6 | $0 (2021) |
| Allergan Inc. | $94.68 | 5 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $91.45 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $957.60 | 43 | AstraZeneca Pharmaceuticals LP ($376.01) |
| 2023 | $436.71 | 23 | GlaxoSmithKline, LLC. ($111.18) |
| 2022 | $305.78 | 17 | GlaxoSmithKline, LLC. ($70.86) |
| 2021 | $402.85 | 21 | Biohaven Pharmaceuticals, Inc. ($87.10) |
| 2020 | $153.08 | 9 | Jazz Pharmaceuticals Inc. ($45.05) |
| 2019 | $460.18 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($137.19) |
| 2018 | $421.48 | 28 | AstraZeneca Pharmaceuticals LP ($80.52) |
| 2017 | $203.80 | 13 | GlaxoSmithKline, LLC. ($56.16) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $28.43 | General |
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $26.73 | General |
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $56.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.17 | General |
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.85 | General |
| 07/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Bone Health | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.32 | General |
| 05/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.58 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 125 | 175 | $23,430 | $14,745 |
| 2022 | 4 | 150 | 233 | $29,870 | $17,672 |
| 2021 | 2 | 104 | 159 | $21,440 | $14,409 |
| 2020 | 7 | 154 | 211 | $29,825 | $13,113 |
Total Patients
533
Total Services
778
Medicare Billing
$59,939
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $9,760 | $8,008 | 82.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 93 | $12,020 | $6,083 | 50.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 21 | $1,650 | $653.86 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 137 | $16,440 | $8,635 | 52.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $9,280 | $7,840 | 84.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 17 | $1,105 | $621.73 | 56.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 21 | $3,045 | $575.52 | 18.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 110 | $13,200 | $7,592 | 57.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $8,240 | $6,817 | 82.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 46 | 46 | $11,960 | $5,559 | 46.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 97 | $11,640 | $5,149 | 44.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 13 | $2,120 | $919.96 | 43.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 11 | 16 | $2,320 | $604.69 | 26.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 14 | $910.00 | $441.45 | 48.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 14 | 14 | $490.00 | $246.47 | 50.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 11 | 11 | $385.00 | $192.18 | 49.9% |
About Dr. John Slattery, MD
Dr. John Slattery, MD is a Family Medicine healthcare provider based in East Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033109236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Slattery, MD has received a total of $3,341 in payments from pharmaceutical and medical device companies, with $957.60 received in 2024. These payments were reported across 185 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,313).
As a Medicare-enrolled provider, Slattery has provided services to 533 Medicare beneficiaries, totaling 778 services with total Medicare billing of $59,939. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location East Greenwich, RI
- Active Since 10/27/2005
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033109236
Products in Payments
- TRELEGY ELLIPTA (Drug) $373.31
- FARXIGA (Drug) $276.45
- Ozempic (Drug) $216.63
- XIFAXAN (Drug) $156.06
- STIOLTO RESPIMAT (Drug) $154.89
- NURTEC ODT (Drug) $143.27
- MOUNJARO (Drug) $142.63
- VYVANSE (Drug) $132.95
- VOQUEZNA (Drug) $118.10
- Rybelsus (Drug) $110.19
- SUNOSI (Drug) $110.14
- BEVESPI AEROSPHERE (Drug) $103.86
- JARDIANCE (Drug) $101.36
- Victoza (Drug) $69.81
- BREZTRI (Drug) $66.34
- SYMBICORT (Drug) $64.21
- UBRELVY (Drug) $63.70
- Wegovy (Drug) $60.13
- VRAYLAR (Drug) $59.66
- APLENZIN (Drug) $54.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in East Greenwich
Dr. Pierre Manzo, Md, MD
Family Medicine — Payments: $5,704
Family Medicine $5,704
Dr. Chad Lamendola, M.d, M.D
Family Medicine — Payments: $4,957
Family Medicine $4,957
Dr. Ellen Hight, Md, MD
Family Medicine — Payments: $4,757
Family Medicine $4,757
Thomas Green, Do, DO
Family Medicine — Payments: $2,474
Family Medicine $2,474
Lauren Goddard, M.d, M.D
Family Medicine — Payments: $559.96
Family Medicine $559.96
Dr. Karen Blackmer, Md, MD
Family Medicine — Payments: $437.03
Family Medicine $437.03